iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionProspera Financial Services Inc
Latest Disclosed Ownership2,699 shares
Latest Disclosed Value $ 455,837
Prospera Financial Services Inc reports 16.94% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 14, 2026 - Prospera Financial Services Inc filed a 13F-HR form disclosing ownership of 2,699 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $455,837 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,308 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 16.94% during the quarter. The current value of the position is $353,704 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,699 391 16.94 456 16.97 0.0073
2026-02-09 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,308 -91 -3.79 390 12.43 0.0064
2025-11-06 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,399 593 32.83 346 51.75 0.0059
2025-08-06 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,806 -643 -26.26 229 -27.16 0.0043
2025-05-15 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,449 -284 -10.39 313 -13.30 0.0072
2025-02-13 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,733 -147 -5.10 361 -13.84 0.0084
2024-11-07 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,880 152 5.57 419 12.03 0.0107
2024-08-13 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,728 -482 -15.02 374 -15.00 0.0104
2024-08-13 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,210 428 15.38 440 16.71 0.0131
2024-02-14 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,782 -466 -14.35 378 -5.04 0.0125
2023-11-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,248 1,406 76.33 397 70.39 0.0154
2023-08-08 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 1,842 -82 -4.26 234 -6.05 0.0090
2023-05-12 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,924 -225 -10.47 249 -12.06 0.0102
2023-02-08 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,149 -138 -6.03 282 5.62 0.0141
2022-10-27 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,287 -229 -9.10 267 -9.80 0.0139
2022-08-08 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,516 -87 -3.34 296 -12.68 0.0151
2022-05-04 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,603 -341 -11.58 339 -24.50 0.0142
2022-02-10 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,944 -324 -9.91 449 -15.12 0.0194
2021-11-12 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,268 -321 -8.94 529 -10.03 0.0264
2021-08-16 2021-06-30 13F/A-1 ISHARES TR ISHARES BIOTECH 464287556 3,589 6 0.17 588 8.89 0.0295
2021-08-12 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,589 6 588 0.0303
2021-05-06 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,583 -767 -17.63 540 -18.06 0.0320
2021-02-12 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 4,350 3,134 257.73 659 299.39 0.0454
2020-11-04 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,216 -2,324 -65.65 165 -65.91 0.0631
2020-08-10 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,540 937 36.00 484 72.24 0.0429
2020-05-15 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,603 2,603 281 0.0298
2019-10-22 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -3,706 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 3,706 3,706 359 0.0724
2019-05-02 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -3,706 -100.00 0 -100.00
2019-02-13 2018-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 3,706 1,859 100.65 359 66.98 0.0724
2018-10-25 2018-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 1,847 1,847 215 0.0401
2017-04-13 2017-03-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -1,102 -100.00 0 -100.00
2017-01-11 2016-12-31 13F ISHARES TR NASDQ BIOTEC ETF 464287556 1,102 1,102 297 0.0582
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.